These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3463556)

  • 21. Cefotetan pharmacokinetics in volunteers with various degrees of renal function.
    Smith BR; LeFrock JL; Thyrum PT; Doret BA; Yeh C; Onesti G; Schwartz A; Zimmerman JJ
    Antimicrob Agents Chemother; 1986 May; 29(5):887-93. PubMed ID: 3460524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients.
    Lee HS; Ti TY; Lye WC; Khoo YM; Tan CC
    Br J Clin Pharmacol; 1996 Jan; 41(1):41-7. PubMed ID: 8824692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.
    Yates RA; Adam HK; Donnelly RJ; Houghton HL; Charlesworth EA; Laws EA
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():185-91. PubMed ID: 6573315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal penetration of cefotetan.
    Wise R; Donovan IA; Drumm J; Dent J; Bennett SA
    Antimicrob Agents Chemother; 1983 Aug; 24(2):279-81. PubMed ID: 6579881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of moxalactam in renal failure.
    Wright N; Wills PJ; Wise R
    J Antimicrob Chemother; 1981 Nov; 8(5):395-9. PubMed ID: 6459316
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
    Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN
    Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.
    Debruyne D; Ryckelynck JP; Moulin M; Hurault de Ligny B; Levaltier B; Bigot MC
    Clin Pharmacokinet; 1990 Jun; 18(6):491-8. PubMed ID: 2354592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failure.
    Donnelly PK; Burwell N; McBurney A; Ward JW; Walls J; Watkin EM
    Br J Radiol; 1992 Dec; 65(780):1108-13. PubMed ID: 1286420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.
    Tjandramaga TB; Verbeeck R; Thomas J; Verbesselt R; Verberckmoes R; Schepper PJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):259-65. PubMed ID: 973960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP; Moulin B; Christmann D
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.